Overbeek, Remco ORCID: 0000-0002-4046-0234, Leitl, Christoph J. ORCID: 0000-0002-6274-5708, Stoll, Sandra E. ORCID: 0000-0002-4803-1362, Wetsch, Wolfgang A. ORCID: 0000-0001-5800-6665, Kammerer, Tobias ORCID: 0000-0001-8920-7187, Mathes, Alexander ORCID: 0000-0002-0231-0681, Böttiger, Bernd W. ORCID: 0000-0001-8000-8931, Seifert, Harald ORCID: 0000-0002-7732-4762, Hart, Dominique ORCID: 0009-0002-0360-1082 and Dusse, Fabian ORCID: 0000-0001-7762-6966 (2024). The Value of Next-Generation Sequencing in Diagnosis and Therapy of Critically Ill Patients with Suspected Bloodstream Infections: A Retrospective Cohort Study. Journal of Clinical Medicine, 13 (2). pp. 1-12. MDPI. ISSN 2077-0383

[thumbnail of jcm-13-00306-v2.pdf] PDF
jcm-13-00306-v2.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (643kB)
Identification Number:10.3390/jcm13020306

Abstract

[Artikel-Nr.: 306] Bloodstream infection (BSI), a frequent cause of severe sepsis, is a life-threatening complication in critically ill patients and still associated with a high mortality rate. Rapid pathogen identification from blood is crucial for an early diagnosis and the treatment of patients with suspected BSI. For this purpose, novel diagnostic tools on the base of genetic analysis have emerged for clinical application. The aim of this study was to assess the diagnostic value of additional next-generation sequencing (NGS) pathogen test for patients with suspected BSI in a surgical ICU and its potential impact on antimicrobial therapy. In this retrospective single-centre study, clinical data and results from blood culture (BC) and NGS pathogen diagnostics were analysed for ICU patients with suspected BSI. Consecutive changes in antimicrobial therapy and diagnostic procedures were evaluated. Results: 41 cases with simultaneous NGS and BC sampling were assessed. NGS showed a statistically non-significant higher positivity rate than BC (NGS: 58.5% (24/41 samples) vs. BC: 21.9% (9/41); p = 0.056). NGS detected eight different potentially relevant bacterial species, one fungus and six different viruses, whereas BC detected four different bacterial species and one fungus. NGS results affected antimicrobial treatment in 7.3% of cases. Conclusions: NGS-based diagnostics have the potential to offer a higher positivity rate than conventional culture-based methods in patients with suspected BSI. Regarding the high cost, their impact on anti-infective therapy is currently limited. Larger randomized prospective clinical multicentre studies are required to assess the clinical benefit of this novel diagnostic technology.

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Overbeek, Remco
UNSPECIFIED
UNSPECIFIED
Leitl, Christoph J.
UNSPECIFIED
UNSPECIFIED
Stoll, Sandra E.
UNSPECIFIED
UNSPECIFIED
Wetsch, Wolfgang A.
UNSPECIFIED
UNSPECIFIED
Kammerer, Tobias
UNSPECIFIED
UNSPECIFIED
Mathes, Alexander
UNSPECIFIED
UNSPECIFIED
Böttiger, Bernd W.
UNSPECIFIED
UNSPECIFIED
Seifert, Harald
UNSPECIFIED
UNSPECIFIED
Hart, Dominique
UNSPECIFIED
UNSPECIFIED
Dusse, Fabian
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-817014
Identification Number: 10.3390/jcm13020306
Journal or Publication Title: Journal of Clinical Medicine
Volume: 13
Number: 2
Page Range: pp. 1-12
Number of Pages: 12
Date: 5 January 2024
Publisher: MDPI
ISSN: 2077-0383
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Anästhesiologie und Operative Intensivmedizin > Klinik für Anästhesiologie und Operative Intensivmedizin
Faculty of Medicine > Medizinische Mikrobiologie, Immunologie und Hygiene > Institut für Medizinische Mikrobiologie, Immunologie und Hygiene
Subjects: Medical sciences Medicine
Uncontrolled Keywords:
Keywords
Language
next-generation sequencing ; sepsis ; antimicrobial therapy ; DISQVER ; pathogen detection ; blood culture
English
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/81701

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item